A 52-year-old man with diabetes mellitus presents to the emergency department with fever (39.2°C), hypotension (BP 88/54 mmHg), tachycardia (HR 118/min), and altered mental status. Blood cultures are drawn. He meets criteria for septic shock. After fluid resuscitation and source control measures, which antibiotic regimen is the first-line empirical choice for community-acquired sepsis in this patient?

Explanation

## First-Line Empirical Therapy for Community-Acquired Sepsis **Key Point:** The Surviving Sepsis Campaign (SSC) and most guidelines recommend broad-spectrum coverage with a third-generation cephalosporin (ceftriaxone) PLUS vancomycin for empirical treatment of community-acquired septic shock pending culture results. ### Rationale for Ceftriaxone + Vancomycin 1. **Broad gram-negative coverage**: Ceftriaxone covers most common gram-negative organisms (E. coli, Klebsiella, Proteus). 2. **Gram-positive coverage including MRSA**: Vancomycin is essential because: - Community-acquired MRSA (CA-MRSA) is increasingly prevalent - Cephalosporins alone do not cover MRSA reliably - Vancomycin achieves excellent tissue penetration, including CNS (relevant given altered mental status) 3. **Rapid onset**: Both agents have rapid bactericidal activity critical in septic shock. 4. **Guideline-endorsed**: Surviving Sepsis Campaign 2021 and most Indian guidelines recommend this combination for community-acquired sepsis. ### Timing **High-Yield:** Antibiotics must be administered within **1 hour** of recognition of sepsis (within 3 hours for non-shock sepsis). Delay in appropriate antibiotics increases mortality. ### Source Control After antibiotics, identify and control the source (e.g., urinary catheterization for UTI, drainage of abscess, etc.). **Clinical Pearl:** In this diabetic patient, consider UTI or aspiration pneumonia as likely sources; ceftriaxone + vancomycin covers both adequately.